Feature Channels:

Women's Health

Add to Favorites | Subscribe | Share


  • (Press "esc" to clear)




A reporter's PressPass is required to access this story until the embargo expires on 19-Dec-2017 11:00 AM EST



Breast Cancer, Surgery, American College Of Surgeons

Many Women Report Not Feeling Completely Informed about Breast Cancer Treatment Options, but Web-Based Tool Could Help

Results from two separate studies in the Journal of the American College of Surgeons showed a decision aid tool may help mitigate the sense of urgency patients feel about making treatment decisions.



Cancer, Cervical Cancer, Brachytherapy, Timothy Showalter, University Of Virginia, University of Virginia Cancer Center, University of Virginia School of Medicine, External Beam Radiation, Oncology, Cancer Treatment, cervical cancer treatment, Best Practices, best treatment for cervical cancer, Medical Research, Research, Medical Costs, Healthcare Costs, H

A Gold-Standard Cancer Treatment Is in Decline, and Money May Be Why.


Researchers have determined that offering brachytherapy for cervical cancer ends up costing hospitals money. That can leave hospitals -- and their patients -- in the lurch.



cancer advances, Breast Cancer, Gene, Genetic Variation, SNPs, Early Onset, Women's Health

Scientists Pinpoint Gene to Blame for Poorer Survival Rate in Early-Onset Breast Cancer Patients

A new study led by scientists at the University of Southampton has found that inherited variation in a particular gene may be to blame for the lower survival rate of patients diagnosed with early-onset breast cancer.



Fertility, Miscarriage, Cells, Natural Killer Cells

Womb Natural Killer Cell Discovery Could Lead to Screening for Miscarriage Risk


For the first time the functions of natural killer cells in the womb have been identified.


Arts and Humanities


the Mount Sinai Health System, Icahn School of Medicine at Mount Sinai, Dubin Breast Center, Tisch Cancer Institute, Kara DioGuardi, Immunotherapy, Breast Cancer

Sixth Annual Benefit Raises More Than $3.4 Million for the Dubin Breast Center


The Dubin Breast Center of The Tisch Cancer Institute at the Mount Sinai Health System held its sixth annual benefit on Monday, December 11, 2017, at the Ziegfeld Ballroom in Manhattan.



UCLA Study Finds Link Between Breast Cancer Treatments and Cellular Markers of Aging


A new study has found that women who had received chemotherapy and/or radiation to treat breast cancer were more likely to have high levels of DNA damage and reduced activity of an enzyme involved in chromosome healing, compared to women who underwent surgery alone. The results suggest that some breast cancer survivors may be more vulnerable to biological changes associated with accelerated aging because of their prior treatment.



Gene Editing, Gene Therapy, Center for Individualized Medicine, Genetic Engineering

Mayo Clinic Bioethicist Megan Allyse, ph.d., Discusses 4 Key Things to Know About the Possibilities, Pitfalls of Gene Editing

Gene editing has captivated scientists and medical providers with tantalizing visions of wiping out debilitating inherited diseases.



Nitric Oxide, CVD-preventive measures, CVD, Women's Health, Nathan Bryan, Ph.D., Felice Gersh, Ernst Schwarz, David Lefer, Age-related Diseases, Anti-aging medicine, nitric oxide function, Cardiovacular Disease, post-menopausal women, cognitive health, Sexual Function, Eriticle , eritile dysfunction, Hypertension, A4M Annual World Congress

Clinicians Who Ignore Nitric Oxide (NO) Function Put Their Patients at Risk

Dr. Nathan Bryan, Baylor College of Medicine and one of the leading experts in nitric oxide biochemistry and physiology said today, “healthcare providers, especially those helping patients with cardiovascular issues and age-related disease, are not using perhaps the most important ‘tool’ in their ‘toolbox,’ restoring nitric oxide function. Bryan organized and chaired a full day workshop on the Clinical Applications of Nitric Oxide held during the 25th American Academy of Anti-Aging Medicine World Congress.



Bioethics, Ethics, fetal therapy , Jeremy Sugarman

Bioethicists Call for Caution in Use of Rare Experimental Fetal Therapy


Citing uncertainties about the risks and benefits of an experimental therapy for fetuses whose kidneys do not develop, bioethicists at Johns Hopkins and a team of medical experts are calling for rigorous clinical trials in the use of a potential treatment, known as amnioinfusion.

Chat now!